Treatment outcome in hippocampal sclerosis with intractable epilepsy after temporal lobe resection in King Chulalongkorn Memorial Hospital

Authors

  • วรัญยู ศรีสุวรรณ หน่วยประสาทศัลยศาสตร์ ภาควิชา ศัลยศาสตร์ คณะแพทยศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย
  • กฤษณพันธ์ บุณยะรัตเวช หน่วยประสาทศัลยศาสตร์ ภาควิชา ศัลยศาสตร์ คณะแพทยศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย

Keywords:

Hippocampal Sclerosis, Engelûs Classification, Seizure free, Non-Seizure free, Mesial temporal lobe epilepsy (MTLE), Anteromesial temporal lobectomy (AMTL)

Abstract

Hippocampal sclerosis is the leading condition found in medically intractable temporal lobe epileptic patients for which temporal lobectomy is an effective treatment option. In this study, the authors sought to investigate the effectiveness and negative predictive factors of this surgical treatment at King Chulalongkorn Memorial Hospital. During 1 January 2011-30 June 2016, eighty-three patients (47 females and 36 males) underwent temporal lobectomy performed by the senior author. The mean age of the seizure onset and the mean age at time of surgery was 13.71 ± 7.99 and 37.34 ± 10.52 years, respectively. The mean duration of follow up was 3.25 ± 1.5 years. At two-year follow-up, there were 79 patients and their Engelûs classification postoperative outcome were I, II, III and IV in 72 (91.1%), 3 (3.8%), 0 (0%) and 4 (5.1%) patients, respectively. The negative predictive factors identified in non-seizure-free patients are poor medical and follow-up compliance, discordant EEG data, bilateral hippocampal sclerosis and a history of central nervous system infection. All of these findings are useful during preoperative patient counselling.

Downloads

Download data is not yet available.

References

Bien CG, Raabe AL, Schramm J, Becker A, Urbach H, Elger CE. Trends in presurgical evaluation and surgical treatment of epilepsy at one centre from 1988- 2009. J Neurol Neurosurg Psychiatry 2013;84(1): 54-61. https://doi.org/10.1136/jnnp-2011-301763.

de Tisi J, Bell GS, Peacock JL, McEvoy AW, Harkness WF, Sander JW, et al. The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study. Lancet 2011;378(9800): 1388-95. https://doi.org/10.1016/S0140- 6736(11)60890-8.

Engel J, McDermott MP, Wiebe S, Langfitt JT, Stern JM, Dewar S, et al. Early surgical therapy for drugresistant temporal lobe epilepsy: a randomized trial. JAMA 2012;307(9):922-30. https://doi.org/10.1001/jama.2012.220

Engel J, Wiebe S, French J, Sperling M, Williamson P, Spencer D, et al. Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology. 2003;60(4):538-47. https://doi.org/10.1212/01.wnl.0000055086.35806.2d

Jobst BC, Cascino GD. Resective epilepsy surgery for drug-resistant focal epilepsy: a review. JAMA. 2015;313(3):285-93. https://doi.org/10.1001/jama.2014.17426

Mathon B, Bedos Ulvin L, Adam C, Baulac M, Dupont S, Navarro V, et al. Surgical treatment for mesial temporal lobe epilepsy associated with hippocampal sclerosis. Rev Neurol (Paris) 2015;171(3):315-25. https://doi.org/10.1016/j.neurol.2015.01.561

Spencer SS, Berg AT, Vickrey BG, Sperling MR, Bazil CW, Haut S, et al. Health-related quality of life over time since resective epilepsy surgery. Ann Neurol. 2007;62(4):327-334. https://doi.org/10.1002/ana.21131

Wiebe S, Blume WT, Girvin JP, Eliasziw M, Effectiveness, Efficiency of Surgery for Temporal Lobe Epilepsy Study G. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001; 345(5):311-8. https://doi.org/10.1056/ NEJM200108023450501

Engel J, Van Ness PC, Rasmussen TB. Outcome with respect to epileptic seizures. In: Engel J, editor. Surgical Treatment of the Epilepsies. 2nd ed. New York: Raven Press; 1993. p. 609-21.

Wieser HG, Blume WT, Fish D, Goldensohn E, Hufnagel A, King D, et al. ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia 2001;42(2):282-6.

Srikijvilaikul T, Lerdlum S, Tepmongkol S, Shuangshoti S. Outcomes after temporal lobectomy for temporal lobe epilepsy with hippocampal sclerosis. J Med Assoc Thai 2012;95(9):1173-77.

Srikijvilaikul T, Limotai C. Long-term seizure outcomes after temporal lobectomy for hippocampal sclerosis. J Med Assoc Thai 2018;101(1):48-52.

Srikijvilaikul T, Bunyaratavej K, Deesudchit T, Tepmongkol S, Lerdlum S, Locharernkul C. Outcome after temporal lobectomy for hippocampal sclerosis: Chulalongkorn Comprehensive Epilepsy Program experiences. Neurology Asia 2004;9:127.

Downloads

Published

2025-10-04

How to Cite

ศรีสุวรรณ ว., & บุณยะรัตเวช ก. (2025). Treatment outcome in hippocampal sclerosis with intractable epilepsy after temporal lobe resection in King Chulalongkorn Memorial Hospital. Thai Journal of Neurological Surgery, 11(1), 22–28. retrieved from https://he05.tci-thaijo.org/index.php/TJNS/article/view/6755

Issue

Section

Original articles